How Far Are Non-Viral Vectors to Come of Age and Reach Clinical Translation in Gene Therapy?
Efficient delivery of genetic material into cells is a critical process to translate gene therapy into clinical practice. In this sense, the increased knowledge acquired during past years in the molecular biology and nanotechnology fields has contributed to the development of different kinds of non-...
Main Authors: | Myriam Sainz-Ramos, Idoia Gallego, Ilia Villate-Beitia, Jon Zarate, Iván Maldonado, Gustavo Puras, Jose Luis Pedraz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/14/7545 |
Similar Items
-
Niosome-Based Approach for In Situ Gene Delivery to Retina and Brain Cortex as Immune-Privileged Tissues
by: Nuseibah AL Qtaish, et al.
Published: (2020-02-01) -
Carbon-Based Nanostructures as Emerging Materials for Gene Delivery Applications
by: Sara Yazdani, et al.
Published: (2024-02-01) -
Nanotechnology-based non-viral vectors for gene delivery in cardiovascular diseases
by: Liping Jiao, et al.
Published: (2024-01-01) -
Correlation between Biophysical Properties of Niosomes Elaborated with Chloroquine and Different Tensioactives and Their Transfection Efficiency
by: Myriam Sainz-Ramos, et al.
Published: (2021-10-01) -
Cancer gene therapy goes viral: viral vector platforms come of age
by: Bezeljak Urban
Published: (2022-02-01)